This is a Validated Antibody Database (VAD) review about chicken CTNNB1, based on 147 published articles (read how Labome selects the articles), using CTNNB1 antibody in all methods. It is aimed to help Labome visitors find the most suited CTNNB1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CTNNB1 synonym: CHBCAT

Knockout validation
Abcam
domestic rabbit polyclonal
  • immunohistochemistry knockout validation; mouse; 1:1000; fig 2b
Abcam CTNNB1 antibody (Abcam, Ab2365) was used in immunohistochemistry knockout validation on mouse samples at 1:1000 (fig 2b). Arthritis Res Ther (2019) ncbi
Invitrogen
domestic rabbit polyclonal (CAT-15)
Invitrogen CTNNB1 antibody (Thermo Fisher, 71-2700) was used . FASEB J (2019) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:300; loading ...; tbl 1
In order to study the expression of troy in human stomach mucosa and intestinal type gastric cancer, Invitrogen CTNNB1 antibody (Life Technologies, Cat-5H10) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 1). Oncotarget (2017) ncbi
domestic rabbit polyclonal (CAT-15)
  • western blot; mouse; loading ...; fig 4f
In order to study meiotic germ cell antigens, Invitrogen CTNNB1 antibody (Invitrogen, 71-2700) was used in western blot on mouse samples (fig 4f). J Clin Invest (2017) ncbi
mouse monoclonal (CAT-5H10)
  • western blot; human; 1:500; loading ...; fig 5b
In order to investigate the expression and function of SOX12 in acute myeloid leukemia, Invitrogen CTNNB1 antibody (Invitrogen, 13-8400) was used in western blot on human samples at 1:500 (fig 5b). Br J Haematol (2017) ncbi
domestic rabbit polyclonal (CAT-15)
  • immunocytochemistry; rat; 1:100; loading ...; fig 3b
  • western blot; rat; 1:250; loading ...; fig 3a
In order to explore how laminin2 in the basement membrane modulates the blood testis barrier dynamics during spermatogenesis, Invitrogen CTNNB1 antibody (ThermoFisher Scientific, 71-2700) was used in immunocytochemistry on rat samples at 1:100 (fig 3b) and in western blot on rat samples at 1:250 (fig 3a). FASEB J (2017) ncbi
mouse monoclonal (CAT-5H10)
  • immunocytochemistry; human; loading ...; fig 3b
In order to show that apical polarization of the sodium, potassium-ATPase in retinal pigment epithelium cells depends on the expression of the beta2 subunit, Invitrogen CTNNB1 antibody (Invitrogen, 13-8400) was used in immunocytochemistry on human samples (fig 3b). Front Physiol (2016) ncbi
domestic rabbit polyclonal (CAT-15)
  • immunocytochemistry; rat; 1:500; loading ...; tbl 1
  • western blot; rat; 1:1000; loading ...; tbl 1
In order to examine the organization of actin microfilaments in Sertoli cell at the blood testis barrier, Invitrogen CTNNB1 antibody (Invitrogen, 71-2700) was used in immunocytochemistry on rat samples at 1:500 (tbl 1) and in western blot on rat samples at 1:1000 (tbl 1). Spermatogenesis (2016) ncbi
mouse monoclonal (CAT-5H10)
  • immunocytochemistry; human; fig 1
In order to propose that IL-1beta and Helicobacter pylori CagA target the beta-catenin pathway, Invitrogen CTNNB1 antibody (Invitrogen, 138400) was used in immunocytochemistry on human samples (fig 1). Gastroenterol Res Pract (2016) ncbi
mouse monoclonal (CAT-5H10)
  • western blot; mouse; 1:1000; fig 5a
In order to investigate the role of paracrine nitric oxide in cardiac progenitor cells, Invitrogen CTNNB1 antibody (Invitrogen, 13-8400) was used in western blot on mouse samples at 1:1000 (fig 5a). Cardiovasc Res (2016) ncbi
mouse monoclonal (CAT-5H10)
  • immunocytochemistry; rat; 1:100; fig 1
  • western blot; rat; 1:500; fig 1
In order to characterize overexpression of gap junction protein connexin 43 by rescue of perfluorooctanesulfonate (PFOS)-mediated sertoli cell injury, Invitrogen CTNNB1 antibody (Invitrogen, 13-8400) was used in immunocytochemistry on rat samples at 1:100 (fig 1) and in western blot on rat samples at 1:500 (fig 1). Sci Rep (2016) ncbi
domestic rabbit polyclonal (CAT-15)
  • immunocytochemistry; mouse; fig 5
In order to determine the reduction of proliferation in embryonic stem cells via FOXO3A/beta-catenin-dependent transcription of p21(cip1) caused by glucose-induced oxidative stress, Invitrogen CTNNB1 antibody (Life Technologies, 71-2700) was used in immunocytochemistry on mouse samples (fig 5). Stem Cell Reports (2016) ncbi
domestic rabbit polyclonal (CAT-15)
  • immunocytochemistry; rat; 1:100; fig 5
  • western blot; rat; 1:250; fig 5
In order to report that crumbs homolog 3 is an actin microfilament regulator, Invitrogen CTNNB1 antibody (Invitrogen, Life Technologies, 71-2700) was used in immunocytochemistry on rat samples at 1:100 (fig 5) and in western blot on rat samples at 1:250 (fig 5). Sci Rep (2016) ncbi
domestic rabbit polyclonal (CAT-15)
  • immunocytochemistry; human; fig 1
In order to study the direct alteration of thrombotic potential of endothelial cells and the hemodynamics associated with atrial fibrillation, Invitrogen CTNNB1 antibody (Life Technologies, 71-2700) was used in immunocytochemistry on human samples (fig 1). Thromb Res (2016) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; dogs; 1:100; loading ...; fig 1a
In order to examine E-cadherin and beta-catenin localization during implantation in dogs, Invitrogen CTNNB1 antibody (Invitrogen, CAT-5H10) was used in immunohistochemistry - paraffin section on dogs samples at 1:100 (fig 1a). Theriogenology (2016) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; mouse; 1:500; fig 7
  • western blot; mouse; fig 8
In order to characterize the association with pancreatic islet redistribution of cell adhesion molecules (CAMS) and reduced insulin secretion function in diabetic mice after prolonged high-fat diet, Invitrogen CTNNB1 antibody (Invitrogen, 138400) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 7) and in western blot on mouse samples (fig 8). Histochem Cell Biol (2016) ncbi
mouse monoclonal (CAT-5H10)
  • immunocytochemistry; rat; 1:100; fig 3
  • western blot; rat; 1:300; fig 3
In order to determine regulation of ectoplasmic specialization dynamics via its effects on actin microfilaments in the testes of male rats by planar cell polarity (PCP) protein Vangl2, Invitrogen CTNNB1 antibody (Invitrogen, 138400) was used in immunocytochemistry on rat samples at 1:100 (fig 3) and in western blot on rat samples at 1:300 (fig 3). Endocrinology (2016) ncbi
mouse monoclonal (CAT-5H10)
  • western blot; human; fig 5
In order to study microRNAs in triple-negative breast cancer, Invitrogen CTNNB1 antibody (ZYMED, 13-8400) was used in western blot on human samples (fig 5). Oncotarget (2016) ncbi
domestic rabbit polyclonal (CAT-15)
  • western blot; mouse; fig 8
  • immunoprecipitation; human; fig s5
  • western blot; human; fig 4
In order to learn about inhibition of stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/beta-catenin signaling axis via cucurbitacin B, Invitrogen CTNNB1 antibody (Invitrogen, 71-2700) was used in western blot on mouse samples (fig 8), in immunoprecipitation on human samples (fig s5) and in western blot on human samples (fig 4). Sci Rep (2016) ncbi
domestic rabbit polyclonal (CAT-15)
  • immunohistochemistry - paraffin section; human; 1:200; fig 3
In order to study an in vitro model for tumor progression modeling and drug screening by using a reductionist metastasis-on-a-chip platform, Invitrogen CTNNB1 antibody (Invitrogen, 71-2700) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3). Biotechnol Bioeng (2016) ncbi
domestic rabbit polyclonal (CAT-15)
  • immunocytochemistry; rat; fig 1
  • western blot; rat; 1:400; fig 2
In order to characterize disruption of the sertolic cell cytoskeleton by interleukin 1alpha and its affect on gap junctional communication, Invitrogen CTNNB1 antibody (Invitrogen, 71-2700) was used in immunocytochemistry on rat samples (fig 1) and in western blot on rat samples at 1:400 (fig 2). Cell Signal (2016) ncbi
mouse monoclonal (CAT-5H10)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, Invitrogen CTNNB1 antibody (INVITROGEN, CAT-5H10) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (CAT-5H10)
  • immunocytochemistry; human; 1:50
  • western blot; human; 1:2000; fig 2a
In order to characterize two clones from triple negative breast MDA-MB-231 cancer cells, Invitrogen CTNNB1 antibody (Invitrogene, 138400) was used in immunocytochemistry on human samples at 1:50 and in western blot on human samples at 1:2000 (fig 2a). Exp Cell Res (2015) ncbi
domestic rabbit polyclonal
In order to use gold nanoparticle-DNA aptamer conjugated to the functional domain of DDR2 to target lung cancer cells, Invitrogen CTNNB1 antibody (Thermo Scientific, PA5-16762) was used . Biochem Biophys Res Commun (2015) ncbi
domestic rabbit polyclonal (CAT-15)
In order to study the role of plastin 3 in ectoplasmic specialization dynamics during spermatogenesis in the rat testis, Invitrogen CTNNB1 antibody (Invitrogen, 71-2700) was used . FASEB J (2015) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:300
In order to discuss catenin expression in feline mammary tissues, Invitrogen CTNNB1 antibody (Zymed/Invitrogen, CAT-5H10) was used in immunohistochemistry - paraffin section on human samples at 1:300. Anticancer Res (2015) ncbi
mouse monoclonal (CAT-5H10)
  • immunocytochemistry; human; 1:100; fig 1d
In order to analyze proliferation and homing of multiple myeloma cells promoted by the cyclophilin A-CD147 complex, Invitrogen CTNNB1 antibody (Zymed, CAT5-H10) was used in immunocytochemistry on human samples at 1:100 (fig 1d). Nat Med (2015) ncbi
domestic rabbit polyclonal (CAT-15)
In order to test if flutamide-induced androgen deficiency during mid- and late pregnancy alters luteal expression of adherens junction protein, beta-catenin, and E-cadherin, Invitrogen CTNNB1 antibody (Invitrogen, 71- 2700) was used . Histol Histopathol (2015) ncbi
domestic rabbit polyclonal (CAT-15)
In order to study the effect of flutamide on the distribution of c-Src and the N-cadherin-beta-catenin complex in the seminiferous epithelium of adult rat, Invitrogen CTNNB1 antibody (Invitrogen, 71-2700) was used . Andrology (2015) ncbi
domestic rabbit polyclonal (CAT-15)
In order to investigate using liver-tumor organoids for in vitro modeling of liver metastasis, Invitrogen CTNNB1 antibody (Invitrogen, 71-2700) was used . Ann Biomed Eng (2015) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry; rat; 1:500
Invitrogen CTNNB1 antibody (Invitrogen, CAT-5H10) was used in immunohistochemistry on rat samples at 1:500. Exp Mol Pathol (2015) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry; mouse; 1:100; fig 6
In order to characterize the inner CSF-brain barrier and controlled access to the brain via intercellular junctions, Invitrogen CTNNB1 antibody (Zymed, 13-8400) was used in immunohistochemistry on mouse samples at 1:100 (fig 6). Front Neurosci (2015) ncbi
domestic rabbit polyclonal (CAT-15)
In order to study the role of Musashi-1 in blood-testis barrier structure during spermatogenesis, Invitrogen CTNNB1 antibody (Invitrogen, 71-2700) was used . Mol Biol Cell (2015) ncbi
mouse monoclonal (CAT-5H10)
  • western blot; human; 1:1000; fig 4
In order to characterize multidrug-resistant cancer cells and attenuation of proteasome inhibitor-mediated apoptosis by ABCB1 expression and Wnt pathway activation, Invitrogen CTNNB1 antibody (Invitrogen, 138400) was used in western blot on human samples at 1:1000 (fig 4). Cancer Biol Ther (2015) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:1000
In order to study the regulatory mechanism of beta-catenin on tumor metastasis, Invitrogen CTNNB1 antibody (Zymed Laboratories, 5H10) was used in immunohistochemistry - paraffin section on human samples at 1:1000. Exp Ther Med (2015) ncbi
mouse monoclonal (CAT-5H10)
  • western blot; human
In order to study the role of Wnt5A signaling in cancer drug resistance, Invitrogen CTNNB1 antibody (Invitrogen, 13-8400) was used in western blot on human samples . Oncotarget (2014) ncbi
mouse monoclonal (CAT-5H10)
  • immunocytochemistry; human
In order to study the effect of HNF4alpha on the chemosensitivity to oxaliplatin and 5-FU in renal cell carcinoma, Invitrogen CTNNB1 antibody (Life Technologies, 13-8400) was used in immunocytochemistry on human samples . J Pharm Sci (2014) ncbi
mouse monoclonal (CAT-5H10)
  • western blot; human
In order to evaluate a novel neuroprotective strategy in hypoxic hippocampal cells, Invitrogen CTNNB1 antibody (Invitrogen, 13-8400) was used in western blot on human samples . Surgery (2014) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:1000
In order to characterize a well-differentiated fetal lung adenocarcinoma from a human, Invitrogen CTNNB1 antibody (Zymed Laboratorys, 5H10) was used in immunohistochemistry - paraffin section on human samples at 1:1000. Chin J Cancer Res (2014) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; dogs; 1:150
In order to determine the expression of E-cadherin, beta-catenin, and Ki-67 in canine prostatic lesions, Invitrogen CTNNB1 antibody (Zymed, CAT5H10) was used in immunohistochemistry - paraffin section on dogs samples at 1:150. Pak J Biol Sci (2013) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry; human; 1:2000
Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunohistochemistry on human samples at 1:2000. Hum Pathol (2014) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry; human; fig 2
In order to examine the association of beta-catenin with pathological parameters and oncologic outcomes in patients with clear cell renal cell carcinoma, Invitrogen CTNNB1 antibody (Invitrogen, 5H10) was used in immunohistochemistry on human samples (fig 2). J Urol (2014) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:200
In order to assess the prognostic significance of the epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma, Invitrogen CTNNB1 antibody (Invitrogen, CAT-5H10) was used in immunohistochemistry - paraffin section on human samples at 1:200. J Clin Pathol (2014) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry; human; 1:1500; tbl 1
In order to report on a case of plexiform fibromyxoma of the stomach, Invitrogen CTNNB1 antibody (Invitrogen, CAT-5H10) was used in immunohistochemistry on human samples at 1:1500 (tbl 1). Int J Surg Pathol (2014) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:400; tbl 4
In order to study p53 and a number of other potential markers at the genetic and immunohistochemical levels in ovarian high grade adenocarcinoma patients, Invitrogen CTNNB1 antibody (Invitrogen, clone CAT-5H10) was used in immunohistochemistry - paraffin section on human samples at 1:400 (tbl 4). Pathol Int (2013) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:500; fig 1
In order to test if EMT-related proteins alterations are associated with the clinicopathological features and prognosis in lung adenocarcinoma, Invitrogen CTNNB1 antibody (Zymed, clone CAT-5H10) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1). Diagn Pathol (2013) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry; human; 1:150; fig 2
In order to examine the BRAF mutation in Korean patients with papillary thyroid carcinoma, Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunohistochemistry on human samples at 1:150 (fig 2). J Korean Med Sci (2013) ncbi
mouse monoclonal (CAT-5H10)
  • western blot; human; fig 5
In order to report proof-of-principle studies targeting CDH17 for treating gastric cancer, Invitrogen CTNNB1 antibody (Zymed, 13-8400) was used in western blot on human samples (fig 5). PLoS ONE (2013) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; mouse; 1:75; fig 2
In order to discuss the roles of E-cadherin and beta-catenin in cancer, Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunohistochemistry - paraffin section on mouse samples at 1:75 (fig 2). Urol Int (2013) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry; human; 1:100; tbl 1
In order to investigate the role of Hath1 in colon cancer, Invitrogen CTNNB1 antibody (Invitrogen, clone CAT-5H10) was used in immunohistochemistry on human samples at 1:100 (tbl 1). PLoS ONE (2013) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry; human; 1:3000; fig 1
In order to correlate ALDH1 expression with rectal cancer treatment response and disease outcome, Invitrogen CTNNB1 antibody (Invitrogen, 13-8400) was used in immunohistochemistry on human samples at 1:3000 (fig 1). Hum Pathol (2013) ncbi
mouse monoclonal (CAT-5H10)
  • immunocytochemistry; mouse
  • western blot; mouse
In order to study the intercalated disc of the heart, Invitrogen CTNNB1 antibody (Zymed Laboratories, clone 5H10) was used in immunocytochemistry on mouse samples and in western blot on mouse samples . Dev Biol (2013) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:250; fig 6
In order to ask if NAV3 contributes to tumorigenesis of nervous system tumors, Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunohistochemistry - paraffin section on human samples at 1:250 (fig 6). Genes Chromosomes Cancer (2013) ncbi
mouse monoclonal (CAT-5H10)
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 3
In order to report that lethal toxin targets alveolar epithelial cells, Invitrogen CTNNB1 antibody (Invitrogen, CAT-5H10) was used in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 3). Infect Immun (2012) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry; mouse; 1:600
Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunohistochemistry on mouse samples at 1:600. Environ Toxicol (2014) ncbi
mouse monoclonal (CAT-5H10)
  • western blot; rat; 1:1000; fig 4
In order to use Phoneutria nigriventer spider venom to study the blood brain barrier, Invitrogen CTNNB1 antibody (Zymed, 138400) was used in western blot on rat samples at 1:1000 (fig 4). Neurochem Res (2012) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry; human; fig 2
In order to characterize pulmonary adenocarcinoma with a micropapillary pattern samples, Invitrogen CTNNB1 antibody (Invitrogen, CAT-5H10) was used in immunohistochemistry on human samples (fig 2). Histopathology (2011) ncbi
mouse monoclonal (CAT-5H10)
  • western blot; human; fig 5
In order to examine the effects of histone deacetylases inhibitors on capillary-like sprout formation, Invitrogen CTNNB1 antibody (Invitrogen, 13-8400) was used in western blot on human samples (fig 5). Surgery (2011) ncbi
mouse monoclonal (CAT-5H10)
  • western blot; human; 1:250; fig 2
In order to characterize the expression and identify the cleavage fragments of Dsg2 in colonic epithelial cells, Invitrogen CTNNB1 antibody (Invitrogen, 13-8400) was used in western blot on human samples at 1:250 (fig 2). Cell Adh Migr (2011) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry; rhesus macaque; fig 3
In order to identify function AQP4 isoforms in the organ of Corti of the rat, Invitrogen CTNNB1 antibody (Invitrogen, 138400) was used in immunohistochemistry on rhesus macaque samples (fig 3). Neuroscience (2011) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry; mouse; 1:1000; fig 4
  • western blot; mouse; 1:1000; fig 4
In order to investigate the role of cadherin regulator p120 catenin to the development of kidney tubules, Invitrogen CTNNB1 antibody (Zymed, 13-8400) was used in immunohistochemistry on mouse samples at 1:1000 (fig 4) and in western blot on mouse samples at 1:1000 (fig 4). Development (2011) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
In order to examine the beta-catenin pathway in adnexal tumors, Invitrogen CTNNB1 antibody (Zymed Laboratories, clone CAT-5H10) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). J Cutan Pathol (2011) ncbi
mouse monoclonal (CAT-5H10)
  • western blot; mouse; fig 8
In order to investigate how plakoglobin affects beta-catenin activity in the heart, Invitrogen CTNNB1 antibody (Invitrogen, CAT-5H10) was used in western blot on mouse samples (fig 8). Mol Cell Biol (2011) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; fig 1
In order to report the clinicopathological and immunohistochemical features of goblet cell carcinoid, Invitrogen CTNNB1 antibody (Neomarker, CAT-5H10) was used in immunohistochemistry - paraffin section on human samples (fig 1). Int J Surg Pathol (2010) ncbi
mouse monoclonal (CAT-5H10)
  • western blot; human; fig s7
In order to investigate retinoic acid-mediated neuronal differentiation of human embryonic stem and cancer cells, Invitrogen CTNNB1 antibody (invitrogen, 13-8400) was used in western blot on human samples (fig s7). Differentiation (2010) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:200
In order to compare gene expression profiles of low-grade and high-grade endometrioid endometrial adenocarcinomas, Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunohistochemistry - paraffin section on human samples at 1:200. Int J Gynecol Cancer (2009) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:300; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). J Comp Pathol (2009) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:200
In order to determine the expression of several adhesion molecules and MUC1 in samples from patients with unifocal or multifocal bladder urothelial cell carcinoma in situ, Invitrogen CTNNB1 antibody (Zymed, Cat-SH10) was used in immunohistochemistry - paraffin section on human samples at 1:200. Int J Surg Pathol (2009) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:200
In order to study beta-catenin expression and its prognostic value in advanced colorectal cancer, Invitrogen CTNNB1 antibody (Zymed Laboratories, CAT-5H10) was used in immunohistochemistry - paraffin section on human samples at 1:200. World J Gastroenterol (2008) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:200
In order to determine the dynamic events leading to impaired cell-cell adhesion upon transition to the invasive phenotype of colorectal cancer, Invitrogen CTNNB1 antibody (Zymed Laboratories, CAT-5H10) was used in immunohistochemistry - paraffin section on human samples at 1:200. APMIS (2008) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human
In order to characterize the liver and primary acinar cell carcinoma, Invitrogen CTNNB1 antibody (Zymed, 5H10) was used in immunohistochemistry - paraffin section on human samples . Virchows Arch (2008) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:1500; fig 2
In order to explore the molecular effect of laryngopharyngeal reflux on the cellular expression of E-caherin and beta-catenin, Invitrogen CTNNB1 antibody (Zymed, CAT 5H10) was used in immunohistochemistry - paraffin section on human samples at 1:1500 (fig 2). Eur Arch Otorhinolaryngol (2008) ncbi
mouse monoclonal (CAT-5H10)
  • immunocytochemistry; rat; fig 3
In order to examine the distribution of nectin-1 and afadin during hippocampal synapse formation, Invitrogen CTNNB1 antibody (Zymed, 13-8400) was used in immunocytochemistry on rat samples (fig 3). J Comp Neurol (2008) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry; chicken; 1:100; fig 2H
In order to analyze the effect of cadmium on tissue and cell distribution of cadherins and their intracellular associates in chickens, Invitrogen CTNNB1 antibody (Zymed, 13-8400) was used in immunohistochemistry on chicken samples at 1:100 (fig 2H). Reprod Toxicol (2008) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry; dogs; 1:100
In order to quantify E-cadherin, P-cadherin and beta-catenin expression in canine malignant mammary tumors, Invitrogen CTNNB1 antibody (Zymed Laboratory, CAT-5H10) was used in immunohistochemistry on dogs samples at 1:100. Vet J (2008) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:100
  • immunocytochemistry; human; 1:100
In order to establish a quantitative fluorescence imaging analysis for of protein quantification in slide-mounted tissues, Invitrogen CTNNB1 antibody (Zymed Laboratories, CAT-5H10) was used in immunohistochemistry - paraffin section on human samples at 1:100 and in immunocytochemistry on human samples at 1:100. Cancer Epidemiol Biomarkers Prev (2007) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; fig 2
In order to assess the use of E-cadherin and beta-catenin as markers of nodal metastasis in oral squamous cell carcinoma, Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunohistochemistry - paraffin section on human samples (fig 2). Oral Dis (2007) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2
In order to quantify the expression of E-cadherin and a- and b-catenins that form the cadherin-catenin complex in tumoral vascular invasion in metastatic sentinel lymph node patients, Invitrogen CTNNB1 antibody (Zymed, a CAT 5H10) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). Pathol Res Pract (2007) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; fig 4
In order to correlate the expression of E-cadherin and beta-catenin with the mode of growth and metastatic capacity of canine malignant mammary tumors, Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunohistochemistry - paraffin section on human samples (fig 4). APMIS (2007) ncbi
mouse monoclonal (CAT-5H10)
  • western blot; mouse; 1:1000
In order to examine the effects of mammary gland-specific deletion of Bin1 on initiation and progression of breast cancer in mice, Invitrogen CTNNB1 antibody (Zymed, 5H10) was used in western blot on mouse samples at 1:1000. Cancer Res (2007) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; mouse; 1:400
In order to study the contribution of Shh to hair follicle development, Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunohistochemistry - paraffin section on mouse samples at 1:400. Dev Cell (2007) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry; human; 1:250
In order to characterize solid pseudopapillary neoplasms samples, Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunohistochemistry on human samples at 1:250. Mod Pathol (2006) ncbi
mouse monoclonal (CAT-5H10)
  • immunocytochemistry; dogs
In order to study ouabain-sensitive and -resistant MDCK cells, Invitrogen CTNNB1 antibody (Zymed, 13-8400) was used in immunocytochemistry on dogs samples . Proc Natl Acad Sci U S A (2006) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry; human; 1:400; fig 1
In order to characterize cases of sessile serrated adenoma in order to identify factors that indicate a high risk of transformation, Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunohistochemistry on human samples at 1:400 (fig 1). Am J Clin Pathol (2006) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
In order to examine changes in the testicular beta-catenin in male infertility conditions, Invitrogen CTNNB1 antibody (Zymed, 13-8400) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). Arch Androl (2005) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - frozen section; human
In order to investigate the effect of the plakoglobin mutation in Naxos disease on connexin43, Invitrogen CTNNB1 antibody (Zymed, 5H10) was used in immunohistochemistry - frozen section on human samples . Heart Rhythm (2004) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; mouse
In order to investigate the effect of N-cadherin misexpression in mice, Invitrogen CTNNB1 antibody (Zymed, 5H10) was used in immunohistochemistry - paraffin section on mouse samples . J Cell Biochem (2005) ncbi
mouse monoclonal (CAT-5H10)
  • immunocytochemistry; mouse; fig 3
  • western blot; mouse; fig 4A-B
In order to study the effect of calcium-dependent adhesion, mediated by N-cadherin, on cell signaling during chondrogenesis, Invitrogen CTNNB1 antibody (ZYMED, CAT-5H10) was used in immunocytochemistry on mouse samples (fig 3) and in western blot on mouse samples (fig 4A-B). J Cell Biochem (2005) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; fig 2
In order to study the impact of microsatellite mutations of the adenomatous polyposis coli gene in nephroblastomas, Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunohistochemistry - paraffin section on human samples (fig 2). J Clin Pathol (2005) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:250
In order to determine osteopontin expression is related to tumor infiltration by macrophages and the adhesive capacity of pancreatic ductal adenocarcinomas, undifferentiated pancreatic carcinomas, and osteoclast-like giant cells, Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunohistochemistry - paraffin section on human samples at 1:250. Virchows Arch (2005) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - frozen section; human; 1:2000
  • immunohistochemistry - paraffin section; human; 1:2000
In order to assess the presence and localization of E-cadherin and beta-catenin in normal fetal germ cells and germ cell tumors, Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunohistochemistry - frozen section on human samples at 1:2000 and in immunohistochemistry - paraffin section on human samples at 1:2000. J Pathol (2004) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human
In order to study the involvement of the E-cadherin-catenin adhesion system in the progression of human cutaneous squamous cell carcinoma, Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunohistochemistry - paraffin section on human samples . Am J Dermatopathol (2004) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:250; tbl 1
In order to measure the E- and N-cadherin and beta- and alpha-catenin expression in benign and malignant epithelial neoplasms of the ovary and correlate expression with tumor staging, histological grade, and presence of metastases during evolution, Invitrogen CTNNB1 antibody (ZYMED, CAT-5H10) was used in immunohistochemistry - paraffin section on human samples at 1:250 (tbl 1). Gynecol Oncol (2004) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:750; fig 3
In order to study the role of several fibrosing-related growth factor in the pathogenesis of mesenteric sclerosis and angiopathy in midgut carcinoids, Invitrogen CTNNB1 antibody (Zymed, 5H10) was used in immunohistochemistry - paraffin section on human samples at 1:750 (fig 3). Hum Pathol (2004) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:100
In order to study the contribution of HDAC2 to the development of solid tumors, Invitrogen CTNNB1 antibody (Zymed, 13-8400) was used in immunohistochemistry - paraffin section on human samples at 1:100. Cancer Cell (2004) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
In order to elucidate the relation between the macroscopic growth patterns of gastric carcinoma and the abnormal expression of E-cadherin and alpha- and beta-catenins, Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). J Clin Gastroenterol (2004) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human
In order to study carriers of the I1307K APC mutation, Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunohistochemistry - paraffin section on human samples . Dig Dis Sci (2003) ncbi
mouse monoclonal (CAT-5H10)
  • immunocytochemistry; mouse; 1:100
In order to test if N-cadherin is required for normal myocyte structure and function, Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunocytochemistry on mouse samples at 1:100. J Cell Sci (2003) ncbi
mouse monoclonal (CAT-5H10)
  • EMSA; human; fig 1
In order to test if B. fragilis toxin triggers beta-catenin nuclear signaling in intestinal epithelial cells, Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in EMSA on human samples (fig 1). Gastroenterology (2003) ncbi
mouse monoclonal (CAT-5H10)
  • ELISA; human; 1:400
In order to suggest that Ro106-9920 selectively inhibits an uncharacterized ubiquitination activity associated with LPS- and TNF alpha-induced IkappaB(alpha) degradation and NF-kappaB activation, Invitrogen CTNNB1 antibody (Zymed, 13-8400) was used in ELISA on human samples at 1:400. J Biol Chem (2002) ncbi
mouse monoclonal (CAT-5H10)
  • immunocytochemistry; chicken; 5 ug/ml; fig 5
In order to identify cellular signals that regulate supporting cell proliferation, Invitrogen CTNNB1 antibody (Life Technologies, CAT-5H10) was used in immunocytochemistry on chicken samples at 5 ug/ml (fig 5). J Neurosci (2002) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; tbl 1
In order to discuss using expression of cadherins and catenins as prognosis markers for cancer, Invitrogen CTNNB1 antibody (Zymed, clone CAT-5H10) was used in immunohistochemistry - paraffin section on human samples (tbl 1). J Mammary Gland Biol Neoplasia (2001) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human
In order to determine the immunoexpression of deleted in colon cancer, p53, E-cadherin, and beta-catenin in the duodenal mucosa of children with coeliac disease, Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunohistochemistry - paraffin section on human samples . J Clin Pathol (2001) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; 1:250
In order to elucidate the role of MUC1 in breast carcinoma, Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunohistochemistry - paraffin section on human samples at 1:250. Cancer (2001) ncbi
mouse monoclonal (CAT-5H10)
  • immunoprecipitation; human
  • western blot; human
In order to investigate E-cadherin in prostate cancer samples, Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunoprecipitation on human samples and in western blot on human samples . Cancer Res (2001) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human
In order to discuss the use of cadherin expression to characterize tumors, Invitrogen CTNNB1 antibody (Zymed, 5H10) was used in immunohistochemistry - paraffin section on human samples . Arch Pathol Lab Med (2000) ncbi
mouse monoclonal (CAT-5H10)
  • immunocytochemistry; bovine; 1:100
In order to test if ROCK has a role in thrombin-induced endothelial monolayer hyperpermeability, Invitrogen CTNNB1 antibody (Zymed, 13?C8400) was used in immunocytochemistry on bovine samples at 1:100. Am J Physiol Cell Physiol (2000) ncbi
mouse monoclonal (CAT-5H10)
  • immunocytochemistry; human
In order to investigate how Cryptosporidium induces rearrangement of the host cell cytoskeleton to form the host-parasite junctional complex, Invitrogen CTNNB1 antibody (Zymed, 13-8400) was used in immunocytochemistry on human samples . Infect Immun (2000) ncbi
mouse monoclonal (CAT-5H10)
  • immunoprecipitation; human; fig 7
In order to test if truncation of E-cadherin results in epithelial apoptosis during prostate and mammary involution, Invitrogen CTNNB1 antibody (Zymed, CAT-5H10) was used in immunoprecipitation on human samples (fig 7). J Biol Chem (2000) ncbi
mouse monoclonal (CAT-5H10)
  • immunohistochemistry - paraffin section; human; fig 3
In order to discuss the role of cadherins in tumor development, Invitrogen CTNNB1 antibody (Zymed, 5H10) was used in immunohistochemistry - paraffin section on human samples (fig 3). Cancer (1999) ncbi
Abcam
domestic rabbit polyclonal
  • immunohistochemistry knockout validation; mouse; 1:1000; fig 2b
Abcam CTNNB1 antibody (Abcam, Ab2365) was used in immunohistochemistry knockout validation on mouse samples at 1:1000 (fig 2b). Arthritis Res Ther (2019) ncbi
mouse monoclonal (BC-22)
  • western blot; rat; loading ...; fig 3a
Abcam CTNNB1 antibody (Abcam, ab11350) was used in western blot on rat samples (fig 3a). PLoS ONE (2019) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; mouse; loading ...; fig 3b
Abcam CTNNB1 antibody (Abcam, ab2365) was used in immunocytochemistry on mouse samples (fig 3b). Biochim Biophys Acta Mol Basis Dis (2018) ncbi
domestic rabbit polyclonal
  • immunoprecipitation; mouse; fig 5
In order to determine the reduction of proliferation in embryonic stem cells via FOXO3A/beta-catenin-dependent transcription of p21(cip1) caused by glucose-induced oxidative stress, Abcam CTNNB1 antibody (Abcam, ab2365) was used in immunoprecipitation on mouse samples (fig 5). Stem Cell Reports (2016) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D2F1)
  • western blot; human; 1:1000; loading ...; fig 4b
Cell Signaling Technology CTNNB1 antibody (CST, 4176) was used in western blot on human samples at 1:1000 (fig 4b). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal (D2F1)
  • western blot; human; 1:1000; loading ...; fig 1a
Cell Signaling Technology CTNNB1 antibody (Cell Signaling Technology, 4176s) was used in western blot on human samples at 1:1000 (fig 1a). Mol Med Rep (2020) ncbi
domestic rabbit monoclonal (D2F1)
  • western blot; human; 1:1000; loading ...; fig 4b
Cell Signaling Technology CTNNB1 antibody (Cell Signaling, 4176) was used in western blot on human samples at 1:1000 (fig 4b). BMC Gastroenterol (2019) ncbi
domestic rabbit monoclonal (D2F1)
  • western blot; mouse; 1:1000; loading ...; fig 4c
In order to propose that macrophage-TNF-induced AKT/beta-catenin signaling in Lgr5(+) hair follicle stem cells is important for promoting hair follicle cycling and neogenesis after wounding, Cell Signaling Technology CTNNB1 antibody (CST Signaling, 4176S) was used in western blot on mouse samples at 1:1000 (fig 4c). Nat Commun (2017) ncbi
domestic rabbit monoclonal (D2F1)
  • immunocytochemistry; human; loading ...; fig s1
In order to use machine-learning modeling with high-throughput cellular imaging to predict cellular sensitivity to tumor necrosis factor alpha, Cell Signaling Technology CTNNB1 antibody (Cell Signaling, 4176 S) was used in immunocytochemistry on human samples (fig s1). Sci Rep (2017) ncbi
domestic rabbit monoclonal (D2F1)
  • western blot; mouse; 1:1000; loading ...; fig 2d
  • western blot; human; 1:1000; fig 2c
  • western blot; African green monkey; 1:1000; loading ...; fig 2c
In order to investigate the role of Wnt4 in zona glomerulosa differentiation, Cell Signaling Technology CTNNB1 antibody (Cell Signaling, 4176) was used in western blot on mouse samples at 1:1000 (fig 2d), in western blot on human samples at 1:1000 (fig 2c) and in western blot on African green monkey samples at 1:1000 (fig 2c). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6b
Cell Signaling Technology CTNNB1 antibody (Cell Signaling, 4270) was used in western blot on human samples (fig 6b). Sci Rep (2016) ncbi
domestic rabbit monoclonal (D2F1)
  • immunocytochemistry; human; fig 4
  • western blot; human; 1:1000; fig 4
Cell Signaling Technology CTNNB1 antibody (Cell Signaling Technology, 4176) was used in immunocytochemistry on human samples (fig 4) and in western blot on human samples at 1:1000 (fig 4). Mol Med Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 7
Cell Signaling Technology CTNNB1 antibody (Cell Signaling, 4270) was used in western blot on human samples at 1:1000 (fig 7). J Cell Mol Med (2016) ncbi
domestic rabbit monoclonal (D2F1)
  • western blot; mouse; 1:1000; loading ...; fig 6
Cell Signaling Technology CTNNB1 antibody (Cell Signaling, 4176) was used in western blot on mouse samples at 1:1000 (fig 6). Nat Commun (2015) ncbi
domestic rabbit monoclonal (D2F1)
  • western blot; mouse; 1:1000
In order to investigate the pathways responsible for the epithelial-mesenchymal transition in cells deficient for Cyclin A2, Cell Signaling Technology CTNNB1 antibody (Cell Signaling, 4176) was used in western blot on mouse samples at 1:1000. Carcinogenesis (2015) ncbi
domestic rabbit monoclonal (D2F1)
  • western blot; human; 1:500; fig 5f
In order to perform the first comprehensive Wnt pathway-focused evaluation using the entorhinal cortex and hippocampus from Alzheimer's diseased brains, Cell Signaling Technology CTNNB1 antibody (Cell Signaling Technologies,, D2F1) was used in western blot on human samples at 1:500 (fig 5f). J Neural Transm (Vienna) (2015) ncbi
domestic rabbit monoclonal (D2F1)
  • western blot; human; fig 4
In order to study the molecular mechanisms underlying malignant changes of meningioma cells, Cell Signaling Technology CTNNB1 antibody (Cell Signaling Technology, 4176) was used in western blot on human samples (fig 4). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D2F1)
  • western blot; human; 1:1000; loading ...; fig 5b
In order to determine the effect of ANGPT1 inhibition on ovarian angiogenesis in follicular fluid from women at risk of ovarian hyperstimulation syndrome, Cell Signaling Technology CTNNB1 antibody (Cell Signalling, 4176) was used in western blot on human samples at 1:1000 (fig 5b). Reprod Fertil Dev (2016) ncbi
domestic rabbit monoclonal (D2F1)
  • immunocytochemistry; human; 1:2000; loading ...; fig 5c
  • western blot; human; 1:2000; loading ...; fig 5a
Cell Signaling Technology CTNNB1 antibody (Cell Signaling, 4176) was used in immunocytochemistry on human samples at 1:2000 (fig 5c) and in western blot on human samples at 1:2000 (fig 5a). J Cell Mol Med (2015) ncbi
domestic rabbit monoclonal (D2F1)
  • western blot; human; fig 2
Cell Signaling Technology CTNNB1 antibody (Cell Signaling Tech, 4176) was used in western blot on human samples (fig 2). Oncogene (2015) ncbi
domestic rabbit monoclonal (D2F1)
  • western blot; human
Cell Signaling Technology CTNNB1 antibody (Cell Signaling, 4176) was used in western blot on human samples . PLoS ONE (2014) ncbi
MilliporeSigma
mouse monoclonal (15B8)
  • immunocytochemistry; human; 1:500; loading ...; fig s1-2
  • western blot; mouse; 1:2000; loading ...; fig 2f
MilliporeSigma CTNNB1 antibody (Sigma-Aldrich, C7207) was used in immunocytochemistry on human samples at 1:500 (fig s1-2) and in western blot on mouse samples at 1:2000 (fig 2f). elife (2020) ncbi
mouse monoclonal (15B8)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 1s1a
MilliporeSigma CTNNB1 antibody (Sigma, 15B8) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 1s1a). elife (2020) ncbi
mouse monoclonal (15B8)
MilliporeSigma CTNNB1 antibody (Sigma, C7207) was used . Science (2020) ncbi
mouse monoclonal (15B8)
  • immunohistochemistry; zebrafish ; 1:500; loading ...; fig 4a
MilliporeSigma CTNNB1 antibody (Sigma-Aldrich, C7207) was used in immunohistochemistry on zebrafish samples at 1:500 (fig 4a). elife (2020) ncbi
mouse monoclonal (15B8)
  • immunocytochemistry; mouse; loading ...; fig 2b
MilliporeSigma CTNNB1 antibody (Sigma-Aldrich, C7207) was used in immunocytochemistry on mouse samples (fig 2b). Sci Rep (2018) ncbi
mouse monoclonal (15B8)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig s2d
In order to determine the role of the Msi family of oncoproteins in the intestinal stem cell compartment, MilliporeSigma CTNNB1 antibody (Sigma-Aldrich, C7207) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig s2d). J Cell Biol (2016) ncbi
mouse monoclonal (15B8)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...
In order to develop a model to explain how signaling events and tissue forces coordinate to regulated the patterning apical membrane invaginations, MilliporeSigma CTNNB1 antibody (Sigma, C-7207) was used in immunohistochemistry - paraffin section on mouse samples at 1:500. Integr Biol (Camb) (2016) ncbi
mouse monoclonal (15B8)
  • immunohistochemistry - paraffin section; mouse; 1:1000; fig 1
In order to investigate the heterogeneity in readouts in intestinal crypts in reference to canonical Wnt pathway activity, MilliporeSigma CTNNB1 antibody (Sigma, C7207) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 1). Dev Dyn (2016) ncbi
mouse monoclonal (15B8)
  • immunoprecipitation; human; fig 5
  • immunoprecipitation; mouse; fig 6
MilliporeSigma CTNNB1 antibody (Sigma, C7207) was used in immunoprecipitation on human samples (fig 5) and in immunoprecipitation on mouse samples (fig 6). Mol Cell Biol (2016) ncbi
mouse monoclonal (15B8)
  • immunocytochemistry; human; 1:250; fig s13b
  • western blot; human; 1:1000; fig 8e
MilliporeSigma CTNNB1 antibody (Sigma- Aldrich, C7207) was used in immunocytochemistry on human samples at 1:250 (fig s13b) and in western blot on human samples at 1:1000 (fig 8e). J Biol Chem (2015) ncbi
mouse monoclonal (15B8)
  • immunohistochemistry - paraffin section; mouse; fig 2
MilliporeSigma CTNNB1 antibody (Sigma, 15B8) was used in immunohistochemistry - paraffin section on mouse samples (fig 2). elife (2015) ncbi
mouse monoclonal (15B8)
  • immunohistochemistry - frozen section; zebrafish ; fig s1
  • immunohistochemistry; zebrafish ; 1:200; fig s1
In order to assess beta-catenin-driven liver tumorigenesis in zebrafish by indentifying chemical inhibitors, MilliporeSigma CTNNB1 antibody (Sigma-Aldrich, C-7207) was used in immunohistochemistry - frozen section on zebrafish samples (fig s1) and in immunohistochemistry on zebrafish samples at 1:200 (fig s1). PLoS Genet (2015) ncbi
mouse monoclonal (15B8)
  • immunohistochemistry - paraffin section; human; 1:150
In order to identify master regulators of inflammatory breast cancer, MilliporeSigma CTNNB1 antibody (SIGMA, C7207) was used in immunohistochemistry - paraffin section on human samples at 1:150. J Transl Med (2015) ncbi
mouse monoclonal (15B8)
  • immunohistochemistry; chicken; 1:200; fig 2
  • western blot; chicken; 1:2000; fig 5
In order to report that beta-catenin controls the cell fate and polarity of neuroblasts by modulating the expression and localization of aPKC, MilliporeSigma CTNNB1 antibody (Sigma, C7207) was used in immunohistochemistry on chicken samples at 1:200 (fig 2) and in western blot on chicken samples at 1:2000 (fig 5). Nat Commun (2014) ncbi
mouse monoclonal (15B8)
  • immunocytochemistry; mouse; fig 1
MilliporeSigma CTNNB1 antibody (Sigma, C7207) was used in immunocytochemistry on mouse samples (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (15B8)
  • immunohistochemistry; mouse
MilliporeSigma CTNNB1 antibody (Sigma, C7207) was used in immunohistochemistry on mouse samples . Dev Biol (2008) ncbi
Developmental Studies Hybridoma Bank
mouse monoclonal (PY489-B-catenin)
  • immunocytochemistry; mouse; 1:50; loading ...; fig 7b
Developmental Studies Hybridoma Bank CTNNB1 antibody (DSHB, PY489) was used in immunocytochemistry on mouse samples at 1:50 (fig 7b). EBioMedicine (2020) ncbi
rat monoclonal (NCAT2)
  • immunohistochemistry - free floating section; mouse
  • immunocytochemistry; mouse
In order to examine the role of 14-3-3 proteins during brain development, Developmental Studies Hybridoma Bank CTNNB1 antibody (Developmental Studies Hybridoma Bank, NCAT2) was used in immunohistochemistry - free floating section on mouse samples and in immunocytochemistry on mouse samples . J Neurosci (2014) ncbi
Articles Reviewed
  1. Zhu X, Chen L, Huang B, Li X, Yang L, Hu X, et al. Efficacy and mechanism of the combination of PARP and CDK4/6 inhibitors in the treatment of triple-negative breast cancer. J Exp Clin Cancer Res. 2021;40:122 pubmed publisher
  2. Gumber D, Do M, Suresh Kumar N, Sonavane P, Wu C, Cruz L, et al. Selective activation of FZD7 promotes mesendodermal differentiation of human pluripotent stem cells. elife. 2020;9: pubmed publisher
  3. Liu Y, Jiang B, Cao Y, Chen W, Yin L, Xu Y, et al. High expression levels and localization of Sox5 in dilated cardiomyopathy. Mol Med Rep. 2020;22:948-956 pubmed publisher
  4. Matos I, Asare A, Levorse J, Ouspenskaia T, de la Cruz Racelis J, Schuhmacher L, et al. Progenitors oppositely polarize WNT activators and inhibitors to orchestrate tissue development. elife. 2020;9: pubmed publisher
  5. Weber C, Zhou Y, Lee J, Looger L, Qian G, Ge C, et al. Temperature-dependent sex determination is mediated by pSTAT3 repression of Kdm6b. Science. 2020;368:303-306 pubmed publisher
  6. Schauer A, Pinheiro D, Hauschild R, Heisenberg C. Zebrafish embryonic explants undergo genetically encoded self-assembly. elife. 2020;9: pubmed publisher
  7. Chen F, Liu X, Chen Y, Liu J, Lu H, Wang W, et al. Sphere-induced reprogramming of RPE cells into dual-potential RPE stem-like cells. EBioMedicine. 2020;52:102618 pubmed publisher
  8. Liu Q, Zhou C, Zhang B. Upregulation of musashi1 increases malignancy of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway and predicts a poor prognosis. BMC Gastroenterol. 2019;19:230 pubmed publisher
  9. Xuan F, Yano F, Mori D, Chijimatsu R, Maenohara Y, Nakamoto H, et al. Wnt/β-catenin signaling contributes to articular cartilage homeostasis through lubricin induction in the superficial zone. Arthritis Res Ther. 2019;21:247 pubmed publisher
  10. Alsaeedi F, Wilson R, Candlish C, Ibrahim I, Leitch A, Abdelghany T, et al. Expression of serine/threonine protein kinase SGK1F promotes an hepatoblast state in stem cells directed to differentiate into hepatocytes. PLoS ONE. 2019;14:e0218135 pubmed publisher
  11. Huang K, Ru B, Zhang Y, Chan W, Chow S, Zhang J, et al. Sertoli cell-specific coxsackievirus and adenovirus receptor knockout regulates cell adhesion and gene transcription via β-catenin inactivation and Cdc42 activation. FASEB J. 2019;33:7588-7602 pubmed publisher
  12. Manalo A, Schroer A, Fenix A, Shancer Z, Coogan J, Brolsma T, et al. Loss of CENP-F Results in Dilated Cardiomyopathy with Severe Disruption of Cardiac Myocyte Architecture. Sci Rep. 2018;8:7546 pubmed publisher
  13. Rogerson C, Gissen P. VPS33B and VIPAR are essential for epidermal lamellar body biogenesis and function. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1609-1621 pubmed publisher
  14. Wilhelm F, Böger C, Krüger S, Behrens H, Rocken C. Troy is expressed in human stomach mucosa and a novel putative prognostic marker of intestinal type gastric cancer. Oncotarget. 2017;8:50557-50569 pubmed publisher
  15. Wang X, Chen H, Tian R, Zhang Y, Drutskaya M, Wang C, et al. Macrophages induce AKT/β-catenin-dependent Lgr5+ stem cell activation and hair follicle regeneration through TNF. Nat Commun. 2017;8:14091 pubmed publisher
  16. Loo L, Bougen Zhukov N, Tan W. Early spatiotemporal-specific changes in intermediate signals are predictive of cytotoxic sensitivity to TNFα and co-treatments. Sci Rep. 2017;7:43541 pubmed publisher
  17. Tung K, Harakal J, Qiao H, Rival C, Li J, Paul A, et al. Egress of sperm autoantigen from seminiferous tubules maintains systemic tolerance. J Clin Invest. 2017;127:1046-1060 pubmed publisher
  18. Wan H, Cai J, Chen F, Zhu J, Zhong J, Zhong H. SOX12: a novel potential target for acute myeloid leukaemia. Br J Haematol. 2017;176:421-430 pubmed publisher
  19. Gao Y, Mruk D, Chen H, Lui W, Lee W, Cheng C. Regulation of the blood-testis barrier by a local axis in the testis: role of laminin ?2 in the basement membrane. FASEB J. 2017;31:584-597 pubmed publisher
  20. Yousefi M, Li N, Nakauka Ddamba A, Wang S, Davidow K, Schoenberger J, et al. Msi RNA-binding proteins control reserve intestinal stem cell quiescence. J Cell Biol. 2016;215:401-413 pubmed
  21. Lobato Álvarez J, Roldán M, López Murillo T, González Ramírez R, Bonilla Delgado J, Shoshani L. The Apical Localization of Na+, K+-ATPase in Cultured Human Retinal Pigment Epithelial Cells Depends on Expression of the ?2 Subunit. Front Physiol. 2016;7:450 pubmed
  22. Drelon C, Berthon A, Sahut Barnola I, Mathieu M, Dumontet T, Rodriguez S, et al. PKA inhibits WNT signalling in adrenal cortex zonation and prevents malignant tumour development. Nat Commun. 2016;7:12751 pubmed publisher
  23. Li N, Lee W, Cheng C. Overexpression of plastin 3 in Sertoli cells disrupts actin microfilament bundle homeostasis and perturbs the tight junction barrier. Spermatogenesis. 2016;6:e1206353 pubmed publisher
  24. Arévalo Romero H, Meza I, Vallejo Flores G, Fuentes Panana E. Helicobacter pylori CagA and IL-1? Promote the Epithelial-to-Mesenchymal Transition in a Nontransformed Epithelial Cell Model. Gastroenterol Res Pract. 2016;2016:4969163 pubmed publisher
  25. De Pauw A, Massion P, Sekkali B, André E, Dubroca C, Kmecova J, et al. Paracrine nitric oxide induces expression of cardiac sarcomeric proteins in adult progenitor cells through soluble guanylyl cyclase/cyclic-guanosine monophosphate and Wnt/?-catenin inhibition. Cardiovasc Res. 2016;112:478-90 pubmed publisher
  26. Freddo A, Shoffner S, Shao Y, Taniguchi K, Grosse A, Guysinger M, et al. Coordination of signaling and tissue mechanics during morphogenesis of murine intestinal villi: a role for mitotic cell rounding. Integr Biol (Camb). 2016;8:918-28 pubmed publisher
  27. Li N, Mruk D, Chen H, Wong C, Lee W, Cheng C. Rescue of perfluorooctanesulfonate (PFOS)-mediated Sertoli cell injury by overexpression of gap junction protein connexin 43. Sci Rep. 2016;6:29667 pubmed publisher
  28. McClelland Descalzo D, Satoorian T, Walker L, Sparks N, Pulyanina P, zur Nieden N. Glucose-Induced Oxidative Stress Reduces Proliferation in Embryonic Stem Cells via FOXO3A/?-Catenin-Dependent Transcription of p21(cip1). Stem Cell Reports. 2016;7:55-68 pubmed publisher
  29. Gao Y, Lui W, Lee W, Cheng C. Polarity protein Crumbs homolog-3 (CRB3) regulates ectoplasmic specialization dynamics through its action on F-actin organization in Sertoli cells. Sci Rep. 2016;6:28589 pubmed publisher
  30. Li N, Yousefi M, Nakauka Ddamba A, Tobias J, Jensen S, Morrisey E, et al. Heterogeneity in readouts of canonical wnt pathway activity within intestinal crypts. Dev Dyn. 2016;245:822-33 pubmed publisher
  31. Simmers M, Cole B, Ogletree M, Chen Z, Xu Y, Kong L, et al. Hemodynamics associated with atrial fibrillation directly alters thrombotic potential of endothelial cells. Thromb Res. 2016;143:34-9 pubmed publisher
  32. Payan Carreira R, Pires M, Santos C, Holst B, Colaco J, Rodriguez Martinez H. Immunolocalization of E-cadherin and ?-catenin in the cyclic and early pregnant canine endometrium. Theriogenology. 2016;86:1092-1101 pubmed publisher
  33. Kumar A, Chalamalasetty R, Kennedy M, Thomas S, Inala S, Garriock R, et al. Zfp703 Is a Wnt/?-Catenin Feedback Suppressor Targeting the ?-Catenin/Tcf1 Complex. Mol Cell Biol. 2016;36:1793-802 pubmed publisher
  34. Falcão V, Maschio D, de Fontes C, Oliveira R, Santos Silva J, Almeida A, et al. Reduced insulin secretion function is associated with pancreatic islet redistribution of cell adhesion molecules (CAMS) in diabetic mice after prolonged high-fat diet. Histochem Cell Biol. 2016;146:13-31 pubmed publisher
  35. Chen H, Mruk D, Lee W, Cheng C. Planar Cell Polarity (PCP) Protein Vangl2 Regulates Ectoplasmic Specialization Dynamics via Its Effects on Actin Microfilaments in the Testes of Male Rats. Endocrinology. 2016;157:2140-59 pubmed publisher
  36. Xu X, Zhang Y, Jasper J, Lykken E, Alexander P, Markowitz G, et al. MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer. Oncotarget. 2016;7:20381-94 pubmed publisher
  37. Yang Z, Liu S, Zhu M, Zhang H, Wang J, Xu Q, et al. PS341 inhibits hepatocellular and colorectal cancer cells through the FOXO3/CTNNB1 signaling pathway. Sci Rep. 2016;6:22090 pubmed publisher
  38. Shukla S, Sinha S, Khan S, Kumar S, Singh K, Mitra K, et al. Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis. Sci Rep. 2016;6:21860 pubmed publisher
  39. Skardal A, Devarasetty M, Forsythe S, Atala A, Soker S. A reductionist metastasis-on-a-chip platform for in vitro tumor progression modeling and drug screening. Biotechnol Bioeng. 2016;113:2020-32 pubmed publisher
  40. Chojnacka K, Bilinska B, Mruk D. Interleukin 1alpha-induced disruption of the Sertoli cell cytoskeleton affects gap junctional communication. Cell Signal. 2016;28:469-480 pubmed publisher
  41. Zhang J, Liu J, Li H, Wang J. β-Catenin signaling pathway regulates cisplatin resistance in lung adenocarcinoma cells by upregulating Bcl-xl. Mol Med Rep. 2016;13:2543-51 pubmed publisher
  42. Zhao L, Li S, Gan L, Li C, Qiu Z, Feng Y, et al. Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expression. J Cell Mol Med. 2016;20:842-54 pubmed publisher
  43. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  44. Lin K, Kao S, Lai C, Chen C, Wu C, Hsu H, et al. Tumor Suppressor Lzap Suppresses Wnt/β-Catenin Signaling to Promote Zebrafish Embryonic Ventral Cell Fates via the Suppression of Inhibitory Phosphorylation of Glycogen Synthase Kinase 3. J Biol Chem. 2015;290:29808-19 pubmed publisher
  45. Martínez Revollar G, Garay E, Martín Tapia D, Nava P, Huerta M, Lopez Bayghen E, et al. Heterogeneity between triple negative breast cancer cells due to differential activation of Wnt and PI3K/AKT pathways. Exp Cell Res. 2015;339:67-80 pubmed publisher
  46. Bebee T, Park J, Sheridan K, Warzecha C, Cieply B, Rohacek A, et al. The splicing regulators Esrp1 and Esrp2 direct an epithelial splicing program essential for mammalian development. elife. 2015;4: pubmed publisher
  47. Conde Perez A, Gros G, Longvert C, Pedersen M, Petit V, Aktary Z, et al. A caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activity. Nat Commun. 2015;6:8093 pubmed publisher
  48. Evason K, Francisco M, Juric V, Balakrishnan S, Lopez Pazmino M, Gordan J, et al. Identification of Chemical Inhibitors of β-Catenin-Driven Liver Tumorigenesis in Zebrafish. PLoS Genet. 2015;11:e1005305 pubmed publisher
  49. Kim D, Yeom J, Lee B, Lee K, Bae J, Rhee S. Inhibition of discoidin domain receptor 2-mediated lung cancer cells progression by gold nanoparticle-aptamer-assisted delivery of peptides containing transmembrane-juxtamembrane 1/2 domain. Biochem Biophys Res Commun. 2015;464:392-5 pubmed publisher
  50. Li N, Mruk D, Wong C, Lee W, Han D, Cheng C. Actin-bundling protein plastin 3 is a regulator of ectoplasmic specialization dynamics during spermatogenesis in the rat testis. FASEB J. 2015;29:3788-805 pubmed publisher
  51. Figueira A, Gomes C, Vilhena H, Miranda S, Carvalheira J, de Matos A, et al. Characterization of α-, β- and p120-Catenin Expression in Feline Mammary Tissues and their Relation with E- and P-Cadherin. Anticancer Res. 2015;35:3361-9 pubmed
  52. Zhu D, Wang Z, Zhao J, Calimeri T, Meng J, Hideshima T, et al. The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells. Nat Med. 2015;21:572-80 pubmed publisher
  53. Cheung C, Bendris N, Paul C, Hamieh A, Anouar Y, Hahne M, et al. Cyclin A2 modulates EMT via β-catenin and phospholipase C pathways. Carcinogenesis. 2015;36:914-24 pubmed publisher
  54. Grzesiak M, Mitan A, Janik M, Knapczyk Stwora K, Slomczynska M. Flutamide alters β-catenin expression and distribution, and its interactions with E-cadherin in the porcine corpus luteum of mid- and late pregnancy. Histol Histopathol. 2015;30:1341-52 pubmed publisher
  55. Remo A, Simeone I, Pancione M, Parcesepe P, Finetti P, Cerulo L, et al. Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer. J Transl Med. 2015;13:138 pubmed publisher
  56. Zarzycka M, Chojnacka K, Mruk D, Górowska E, Hejmej A, Kotula Balak M, et al. Flutamide alters the distribution of c-Src and affects the N-cadherin-β-catenin complex in the seminiferous epithelium of adult rat. Andrology. 2015;3:569-81 pubmed publisher
  57. Skardal A, Devarasetty M, Rodman C, Atala A, Soker S. Liver-Tumor Hybrid Organoids for Modeling Tumor Growth and Drug Response In Vitro. Ann Biomed Eng. 2015;43:2361-73 pubmed publisher
  58. Tennakoon A, Izawa T, Wijesundera K, Katou Ichikawa C, Tanaka M, Golbar H, et al. Analysis of glial fibrillary acidic protein (GFAP)-expressing ductular cells in a rat liver cirrhosis model induced by repeated injections of thioacetamide (TAA). Exp Mol Pathol. 2015;98:476-85 pubmed publisher
  59. Whish S, Dziegielewska K, Møllgård K, Noor N, Liddelow S, Habgood M, et al. The inner CSF-brain barrier: developmentally controlled access to the brain via intercellular junctions. Front Neurosci. 2015;9:16 pubmed publisher
  60. ErLin S, WenJie W, LiNing W, BingXin L, MingDe L, Yan S, et al. Musashi-1 maintains blood-testis barrier structure during spermatogenesis and regulates stress granule formation upon heat stress. Mol Biol Cell. 2015;26:1947-56 pubmed publisher
  61. Riise J, Plath N, Pakkenberg B, Parachikova A. Aberrant Wnt signaling pathway in medial temporal lobe structures of Alzheimer's disease. J Neural Transm (Vienna). 2015;122:1303-18 pubmed publisher
  62. Chow H, Dong B, Duron S, Campbell D, Ong C, Hoeflich K, et al. Group I Paks as therapeutic targets in NF2-deficient meningioma. Oncotarget. 2015;6:1981-94 pubmed
  63. Chong K, Hsu C, Hung T, Hu H, Huang T, Wang T, et al. Wnt pathway activation and ABCB1 expression account for attenuation of proteasome inhibitor-mediated apoptosis in multidrug-resistant cancer cells. Cancer Biol Ther. 2015;16:149-59 pubmed publisher
  64. Xu X, Kim J, Sun P, Yoo S, Kim H, Jin Y, et al. Immunohistochemical demonstration of alteration of β-catenin during tumor metastasis by different mechanisms according to histology in lung cancer. Exp Ther Med. 2015;9:311-318 pubmed
  65. Scotti L, Abramovich D, Pascuali N, Durand L, Irusta G, de Zúñiga I, et al. Inhibition of angiopoietin-1 (ANGPT1) affects vascular integrity in ovarian hyperstimulation syndrome (OHSS). Reprod Fertil Dev. 2016;28:690-9 pubmed publisher
  66. Hung T, Hsu S, Cheng C, Choo K, Tseng C, Chen T, et al. Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway. Oncotarget. 2014;5:12273-90 pubmed
  67. Jansen S, Holman R, Hedemann I, Frankes E, Elzinga C, Timens W, et al. Prostaglandin E2 promotes MYCN non-amplified neuroblastoma cell survival via β-catenin stabilization. J Cell Mol Med. 2015;19:210-26 pubmed publisher
  68. Toyo oka K, Wachi T, Hunt R, Baraban S, Taya S, Ramshaw H, et al. 14-3-3ε and ζ regulate neurogenesis and differentiation of neuronal progenitor cells in the developing brain. J Neurosci. 2014;34:12168-81 pubmed publisher
  69. Hagos Y, Wegner W, Kuehne A, Floerl S, Marada V, Burckhardt G, et al. HNF4α induced chemosensitivity to oxaliplatin and 5-FU mediated by OCT1 and CNT3 in renal cell carcinoma. J Pharm Sci. 2014;103:3326-34 pubmed publisher
  70. Jin G, Liu B, You Z, Bambakidis T, Dekker S, Maxwell J, et al. Development of a novel neuroprotective strategy: combined treatment with hypothermia and valproic acid improves survival in hypoxic hippocampal cells. Surgery. 2014;156:221-8 pubmed publisher
  71. Herrera A, Saade M, Menendez A, Marti E, Pons S. Sustained Wnt/?-catenin signalling causes neuroepithelial aberrations through the accumulation of aPKC at the apical pole. Nat Commun. 2014;5:4168 pubmed publisher
  72. Moody S, Schinzel A, Singh S, Izzo F, Strickland M, Luo L, et al. PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signaling. Oncogene. 2015;34:2061-71 pubmed publisher
  73. Elliott V, Rychahou P, Zaytseva Y, Evers B. Activation of c-Met and upregulation of CD44 expression are associated with the metastatic phenotype in the colorectal cancer liver metastasis model. PLoS ONE. 2014;9:e97432 pubmed publisher
  74. Li J, Bai X, Zou Y, Hao Y, Xu X. Aberration of the Wnt signaling pathway in pulmonary fatal adenocarcinoma: a case report. Chin J Cancer Res. 2014;26:E13-6 pubmed publisher
  75. Rodrigues M, Rema A, Gartner M, Laufer Amorim R. Role of adhesion molecules and proliferation hyperplasic, pre neoplastic and neoplastic lesions in canine prostate. Pak J Biol Sci. 2013;16:1324-9 pubmed
  76. Kim S, Kim M, Kim M, Kim S, Choi J, Yu E, et al. Pleomorphic solid pseudopapillary neoplasm of the pancreas: degenerative change rather than high-grade malignant potential. Hum Pathol. 2014;45:166-74 pubmed publisher
  77. Krabbe L, Westerman M, Bagrodia A, Gayed B, Darwish O, Haddad A, et al. Dysregulation of ?-catenin is an independent predictor of oncologic outcomes in patients with clear cell renal cell carcinoma. J Urol. 2014;191:1671-7 pubmed publisher
  78. Gu M, Choi J. Epithelial-mesenchymal transition phenotypes are associated with patient survival in intrahepatic cholangiocarcinoma. J Clin Pathol. 2014;67:229-34 pubmed publisher
  79. Lee P, Yau D, Lau P, Chan J. Plexiform fibromyxoma (plexiform angiomyxoid myofibroblastic tumor) of stomach: an unusual presentation as a fistulating abscess. Int J Surg Pathol. 2014;22:286-90 pubmed publisher
  80. Lee S, Kim H, Kim W, Han H, Lim S, Kim W, et al. Genetic alteration and immunohistochemical staining patterns of ovarian high-grade serous adenocarcinoma with special emphasis on p53 immnnostaining pattern. Pathol Int. 2013;63:252-9 pubmed publisher
  81. Shi Y, Wu H, Zhang M, Ding L, Meng F, Fan X. Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma. Diagn Pathol. 2013;8:89 pubmed publisher
  82. Okumura N, Akutsu H, Sugawara T, Miura T, Takezawa Y, Hosoda A, et al. ?-catenin functions pleiotropically in differentiation and tumorigenesis in mouse embryo-derived stem cells. PLoS ONE. 2013;8:e63265 pubmed publisher
  83. Min H, Lee C, Jung K. Correlation of immunohistochemical markers and BRAF mutation status with histological variants of papillary thyroid carcinoma in the Korean population. J Korean Med Sci. 2013;28:534-41 pubmed publisher
  84. Qiu H, Zhang L, Ren C, Zeng Z, Wu W, Luo H, et al. Targeting CDH17 suppresses tumor progression in gastric cancer by downregulating Wnt/β-catenin signaling. PLoS ONE. 2013;8:e56959 pubmed publisher
  85. Vasconcelos Nóbrega C, Costa C, Vala H, Colaco A, Santos L, Lopes C, et al. E-cadherin and ?-catenin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in mice. Urol Int. 2013;91:462-6 pubmed publisher
  86. Souazé F, Bou Hanna C, Kandel C, Leclair F, Devalliere J, Charreau B, et al. Differential roles of Hath1, MUC2 and P27Kip1 in relation with gamma-secretase inhibition in human colonic carcinomas: a translational study. PLoS ONE. 2013;8:e55904 pubmed publisher
  87. Avoranta S, Korkeila E, Ristamäki R, Syrjanen K, Carpén O, Pyrhönen S, et al. ALDH1 expression indicates chemotherapy resistance and poor outcome in node-negative rectal cancer. Hum Pathol. 2013;44:966-74 pubmed publisher
  88. Wang Q, Lin J, Chan S, Lin J. The Xin repeat-containing protein, mXinβ, initiates the maturation of the intercalated discs during postnatal heart development. Dev Biol. 2013;374:264-80 pubmed publisher
  89. Carlsson E, Krohn K, Ovaska K, Lindberg P, Häyry V, Maliniemi P, et al. Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis. Genes Chromosomes Cancer. 2013;52:191-201 pubmed publisher
  90. Langer M, Duggan E, Booth J, Patel V, Zander R, Silasi Mansat R, et al. Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function. Infect Immun. 2012;80:4374-87 pubmed publisher
  91. Gil da Costa R, Oliveira P, Bastos M, Lopes C, Lopes C. Ptaquiloside-induced early-stage urothelial lesions show increased cell proliferation and intact ?-catenin and E-cadherin expression. Environ Toxicol. 2014;29:763-9 pubmed publisher
  92. Raposo C, Odorissi P, Oliveira A, Aoyama H, Ferreira C, Verinaud L, et al. Effect of Phoneutria nigriventer venom on the expression of junctional protein and P-gp efflux pump function in the blood-brain barrier. Neurochem Res. 2012;37:1967-81 pubmed publisher
  93. Zhang J, Liang Z, Gao J, Luo Y, Liu T. Pulmonary adenocarcinoma with a micropapillary pattern: a clinicopathological, immunophenotypic and molecular analysis. Histopathology. 2011;59:1204-14 pubmed publisher
  94. Jin G, Bausch D, Knightly T, Liu Z, Li Y, Liu B, et al. Histone deacetylase inhibitors enhance endothelial cell sprouting angiogenesis in vitro. Surgery. 2011;150:429-35 pubmed publisher
  95. Kolegraff K, Nava P, Laur O, Parkos C, Nusrat A. Characterization of full-length and proteolytic cleavage fragments of desmoglein-2 in native human colon and colonic epithelial cell lines. Cell Adh Migr. 2011;5:306-14 pubmed
  96. Hirt B, Gleiser C, Eckhard A, Mack A, Muller M, Wolburg H, et al. All functional aquaporin-4 isoforms are expressed in the rat cochlea and contribute to the formation of orthogonal arrays of particles. Neuroscience. 2011;189:79-92 pubmed publisher
  97. MARCIANO D, BRAKEMAN P, Lee C, Spivak N, Eastburn D, Bryant D, et al. p120 catenin is required for normal renal tubulogenesis and glomerulogenesis. Development. 2011;138:2099-109 pubmed publisher
  98. Im M, Kim D, Park J, Chung H, Lee Y, Kim C, et al. Alteration of the ?-catenin pathway in spiradenoma. J Cutan Pathol. 2011;38:657-62 pubmed publisher
  99. Li J, Swope D, Raess N, Cheng L, Muller E, Radice G. Cardiac tissue-restricted deletion of plakoglobin results in progressive cardiomyopathy and activation of {beta}-catenin signaling. Mol Cell Biol. 2011;31:1134-44 pubmed publisher
  100. Yong Jiang -, Huawei Liu -, Hu Long -, Yingying Yang -, Dianying Liao -, Xiuhui Zhang -. Goblet cell carcinoid of the appendix: a clinicopathological and immunohistochemical study of 26 cases from southwest china. Int J Surg Pathol. 2010;18:488-92 pubmed publisher
  101. Tonge P, Andrews P. Retinoic acid directs neuronal differentiation of human pluripotent stem cell lines in a non-cell-autonomous manner. Differentiation. 2010;80:20-30 pubmed publisher
  102. Huvila J, Brandt A, Rojas C, Pasanen S, Talve L, Hirsimäki P, et al. Gene expression profiling of endometrial adenocarcinomas reveals increased apolipoprotein E expression in poorly differentiated tumors. Int J Gynecol Cancer. 2009;19:1226-31 pubmed publisher
  103. Gil da Costa R, Santos M, Amorim I, Lopes C, Pereira P, Faustino A. An immunohistochemical study of feline endometrial adenocarcinoma. J Comp Pathol. 2009;140:254-9 pubmed publisher
  104. Patriarca C, Colombo P, Pio Taronna A, Wesseling J, Franchi G, Guddo F, et al. Cell discohesion and multifocality of carcinoma in situ of the bladder: new insight from the adhesion molecule profile (e-cadherin, Ep-CAM, and MUC1). Int J Surg Pathol. 2009;17:99-106 pubmed publisher
  105. Nair M, Nagamori I, Sun P, Mishra D, Rhéaume C, Li B, et al. Nuclear regulator Pygo2 controls spermiogenesis and histone H3 acetylation. Dev Biol. 2008;320:446-55 pubmed publisher
  106. Elzagheid A, Buhmeida A, Korkeila E, Collan Y, Syrjanen K, Pyrhonen S. Nuclear beta-catenin expression as a prognostic factor in advanced colorectal carcinoma. World J Gastroenterol. 2008;14:3866-71 pubmed
  107. Buhmeida A, Elzagheid A, Algars A, Collan Y, Syrjanen K, Pyrhonen S. Expression of the cell-cell adhesion molecule beta-catenin in colorectal carcinomas and their metastases. APMIS. 2008;116:1-9 pubmed publisher
  108. Hervieu V, Lombard Bohas C, Dumortier J, Boillot O, Scoazec J. Primary acinar cell carcinoma of the liver. Virchows Arch. 2008;452:337-41 pubmed publisher
  109. Reichel O, Mayr D, Durst F, Berghaus A. E-cadherin but not beta-catenin expression is decreased in laryngeal biopsies from patients with laryngopharyngeal reflux. Eur Arch Otorhinolaryngol. 2008;265:937-42 pubmed publisher
  110. Lim S, Lim K, Giuliano R, Federoff H. Temporal and spatial localization of nectin-1 and l-afadin during synaptogenesis in hippocampal neurons. J Comp Neurol. 2008;507:1228-44 pubmed publisher
  111. Thompson J, Wong L, Lau P, Bannigan J. Adherens junction breakdown in the periderm following cadmium administration in the chick embryo: distribution of cadherins and associated molecules. Reprod Toxicol. 2008;25:39-46 pubmed
  112. Gama A, Paredes J, Gartner F, Alves A, Schmitt F. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival. Vet J. 2008;177:45-53 pubmed
  113. Huang D, Casale G, Tian J, Wehbi N, Abrahams N, Kaleem Z, et al. Quantitative fluorescence imaging analysis for cancer biomarker discovery: application to beta-catenin in archived prostate specimens. Cancer Epidemiol Biomarkers Prev. 2007;16:1371-81 pubmed
  114. Mahomed F, Altini M, Meer S. Altered E-cadherin/beta-catenin expression in oral squamous carcinoma with and without nodal metastasis. Oral Dis. 2007;13:386-92 pubmed
  115. Canavese G, Bernardi A, Candelaresi G, Lovadina P, Amerio S, Rossetti V, et al. Expression of the E-cadherin-catenins complex in sentinel node is related to tumor morphology but not to spread to nonsentinel nodes. Pathol Res Pract. 2007;203:517-23 pubmed
  116. De Matos A, Lopes C, Faustino A, Carvalheira J, Rutteman G, Gärtner M. E-cadherin, beta-catenin, invasion and lymph node metastases in canine malignant mammary tumours. APMIS. 2007;115:327-34 pubmed
  117. Chang M, Boulden J, Sutanto Ward E, DuHadaway J, Soler A, Muller A, et al. Bin1 ablation in mammary gland delays tissue remodeling and drives cancer progression. Cancer Res. 2007;67:100-7 pubmed
  118. Gritli Linde A, Hallberg K, Harfe B, Reyahi A, Kannius Janson M, Nilsson J, et al. Abnormal hair development and apparent follicular transformation to mammary gland in the absence of hedgehog signaling. Dev Cell. 2007;12:99-112 pubmed
  119. Tiemann K, Kosmahl M, Ohlendorf J, Krams M, Kloppel G. Solid pseudopapillary neoplasms of the pancreas are associated with FLI-1 expression, but not with EWS/FLI-1 translocation. Mod Pathol. 2006;19:1409-13 pubmed
  120. Larre I, Ponce A, Fiorentino R, Shoshani L, Contreras R, Cereijido M. Contacts and cooperation between cells depend on the hormone ouabain. Proc Natl Acad Sci U S A. 2006;103:10911-6 pubmed
  121. Goldstein N. Small colonic microsatellite unstable adenocarcinomas and high-grade epithelial dysplasias in sessile serrated adenoma polypectomy specimens: a study of eight cases. Am J Clin Pathol. 2006;125:132-45 pubmed
  122. Lee J, Choi K, Lee S, Gye M. Expression of beta-catenin in human testes with spermatogenic defects. Arch Androl. 2005;51:271-6 pubmed
  123. Kaplan S, Gard J, Protonotarios N, Tsatsopoulou A, Spiliopoulou C, Anastasakis A, et al. Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm. 2004;1:3-11 pubmed
  124. Knudsen K, Sauer C, Johnson K, Wheelock M. Effect of N-cadherin misexpression by the mammary epithelium in mice. J Cell Biochem. 2005;95:1093-107 pubmed
  125. Modarresi R, Lafond T, Roman Blas J, Danielson K, Tuan R, Seghatoleslami M. N-cadherin mediated distribution of beta-catenin alters MAP kinase and BMP-2 signaling on chondrogenesis-related gene expression. J Cell Biochem. 2005;95:53-63 pubmed
  126. Ramburan A, Oladiran F, Smith C, Hadley G, Govender D. Microsatellite analysis of the adenomatous polyposis coli (APC) gene and immunoexpression of beta catenin in nephroblastoma: a study including 83 cases treated with preoperative chemotherapy. J Clin Pathol. 2005;58:44-50 pubmed
  127. Sedivy R, Peters K, Kloppel G. Osteopontin expression in ductal adenocarcinomas and undifferentiated carcinomas of the pancreas. Virchows Arch. 2005;446:41-5 pubmed
  128. Honecker F, Kersemaekers A, Molier M, Van Weeren P, Stoop H, de Krijger R, et al. Involvement of E-cadherin and beta-catenin in germ cell tumours and in normal male fetal germ cell development. J Pathol. 2004;204:167-74 pubmed
  129. Lyakhovitsky A, Barzilai A, Fogel M, Trau H, Huszar M. Expression of e-cadherin and beta-catenin in cutaneous squamous cell carcinoma and its precursors. Am J Dermatopathol. 2004;26:372-8 pubmed
  130. Marques F, Fonsechi Carvasan G, de Angelo Andrade L, Bottcher Luiz F. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors. Gynecol Oncol. 2004;94:16-24 pubmed
  131. Zhang P, Furth E, Cai X, Goldblum J, Pasha T, Min K. The role of beta-catenin, TGF beta 3, NGF2, FGF2, IGFR2, and BMP4 in the pathogenesis of mesenteric sclerosis and angiopathy in midgut carcinoids. Hum Pathol. 2004;35:670-4 pubmed
  132. Zhu P, Martin E, Mengwasser J, Schlag P, Janssen K, Göttlicher M. Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell. 2004;5:455-63 pubmed
  133. Song S, Kim S, Kim D, Son H, Rhee J, Kim Y. Abnormal expression of E-cadherin in early gastric carcinoma: its relationship with macroscopic growth patterns and catenin alpha and beta. J Clin Gastroenterol. 2004;38:252-9 pubmed
  134. Fidder H, Barshack I, Chen Shtoyerman R, Onaca N, Goldberg I, Rath P, et al. Immunohistochemical analyses of colon cancer in I1307K APC mutation carriers compared with noncarriers. Dig Dis Sci. 2003;48:1102-5 pubmed
  135. Luo Y, Radice G. Cadherin-mediated adhesion is essential for myofibril continuity across the plasma membrane but not for assembly of the contractile apparatus. J Cell Sci. 2003;116:1471-9 pubmed
  136. Wu S, Morin P, Maouyo D, Sears C. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology. 2003;124:392-400 pubmed
  137. Swinney D, Xu Y, Scarafia L, Lee I, Mak A, Gan Q, et al. A small molecule ubiquitination inhibitor blocks NF-kappa B-dependent cytokine expression in cells and rats. J Biol Chem. 2002;277:23573-81 pubmed
  138. Warchol M. Cell density and N-cadherin interactions regulate cell proliferation in the sensory epithelia of the inner ear. J Neurosci. 2002;22:2607-16 pubmed
  139. Wheelock M, Soler A, Knudsen K. Cadherin junctions in mammary tumors. J Mammary Gland Biol Neoplasia. 2001;6:275-85 pubmed
  140. Barshack I, Goldberg I, Chowers Y, Weiss B, Horowitz A, Kopolovic J. Immunohistochemical analysis of candidate gene product expression in the duodenal epithelium of children with coeliac sprue. J Clin Pathol. 2001;54:684-8 pubmed
  141. Rahn J, Dabbagh L, Pasdar M, Hugh J. The importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literature. Cancer. 2001;91:1973-82 pubmed
  142. Rashid M, Sanda M, Vallorosi C, Rios Doria J, Rubin M, Day M. Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate. Cancer Res. 2001;61:489-92 pubmed
  143. Han A, Soler A, Tang C, Knudsen K, Salazar H. Nuclear localization of E-cadherin expression in Merkel cell carcinoma. Arch Pathol Lab Med. 2000;124:1147-51 pubmed
  144. Carbajal J, Gratrix M, Yu C, Schaeffer R. ROCK mediates thrombin's endothelial barrier dysfunction. Am J Physiol Cell Physiol. 2000;279:C195-204 pubmed
  145. Elliott D, Clark D. Cryptosporidium parvum induces host cell actin accumulation at the host-parasite interface. Infect Immun. 2000;68:2315-22 pubmed
  146. Vallorosi C, Day K, Zhao X, Rashid M, Rubin M, Johnson K, et al. Truncation of the beta-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution. J Biol Chem. 2000;275:3328-34 pubmed
  147. Peralta Soler A, Knudsen K, Salazar H, Han A, Keshgegian A. P-cadherin expression in breast carcinoma indicates poor survival. Cancer. 1999;86:1263-72 pubmed